Dow Up 0.08% Nasdaq Down 0.30%

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
27.13 Up 0.33(1.23%) 4:15PM EDT
|After Hours : 26.53 Down 0.60 (2.21%) 5:27PM EDT
Prev Close:26.80
Open:26.85
Bid:26.55 x 100
Ask:27.09 x 200
1y Target Est:37.77
Beta:0.08
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:26.25 - 27.15
52wk Range:21.60 - 39.68
Volume:3,209,799
Avg Vol (3m):1,892,430
Market Cap:2.89B
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NPSP

Comparison

Symbol% ChgMkt Cap
NPSPUp 1.23%2.89B
ABTDown 0.23%65.55B
BIIBDown 0.23%77.75B

Key Statistics

Forward P/E (1 yr):23.59
P/S (ttm):14.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.02
Quarterly EPS Est (Sep-14) :0.01
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):12.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback